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Abstract
 
In experiments to study the impact of deficiency in CD4
 
 
 
 T cell help on the magnitude of
CD8
 
 
 
 cytotoxic T cell response to pathogens, it was noted that in CD4 gene knockout mice,
the CD8 population made significant responses to several nominally major histocompatibility
complex (MHC) class II–restricted epitopes in addition to the expected responses to MHC
class I–restricted epitopes. A similar response by CD8
 
 
 
 T cells to class II–restricted epitopes was
not observed in wild-type mice, or in mice that had been acutely depleted of CD4
 
 
 
 T cells just
before the immunization. Coincident with this unexpected response to class II–restricted
epitopes, it was also observed that the CD8
 
 
 
 response to the class I–restricted epitopes was
consistently lower in CD4
 
 
 
/
 
 
 
 mice than in wild-type mice. Further experiments suggested that
these two observations are linked and that the CD8 population in CD4
 
 
 
/
 
 
 
 mice may contain a
majority of T cells that were actually selected by recognition of MHC class II molecules in the
thymus. These results have implications for understanding CD4 versus CD8 lineage commitment
in the thymus, and for the practical use of CD4
 
 
 
/
 
 
 
 mice as models of helper deficiency.
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Introduction
 
Mice in which the CD4 gene has been disrupted provide a
model system to analyze the contribution of the CD4
coreceptor to T cell differentiation in the thymus and the
impact of helper T cell deficiency on the humoral and
CD8 T cell response (1, 2). With regard to the former, it has
been shown that in CD4
 
 
 
/
 
 
 
 mice, several class II–restricted
T cells emerge from the thymus as CD4 lineage cells that
express neither CD8 nor CD4, so-called “CD4 wannabe”
 
T cells (1, 2). These CD4
 
 
 
CD8
 
 
 
 double-negative CD4
lineage T cells constitute 10–20% of the peripheral T cell
pool (1–3). It has been supposed that these double-negative
CD4 lineage T cells express TCRs with sufficiently high
affinity for positively selecting ligands in the thymus, such
that they do not require cooperation with the CD4 core-
ceptor to drive maturation to the CD4 lineage. In addition
to these double-negative CD4 lineage T cells, in some class
II–restricted TCR transgenic mice on certain MHC back-
grounds, immature thymocytes that normally differentiate
into the CD4 lineage are mis-selected into the CD8 lineage
in mice lacking CD4 (4). Both of these outcomes can be
explained on the basis of the strength of the signal model of
CD4/CD8 lineage choice, which proposes that quantitative
differences in signal strength direct differentiation to the
CD4 versus CD8 lineage. According to this model, stronger
signals during positive selection direct cells to the CD4 lin-
eage, whereas weaker signals promote CD8 lineage choice
(5–8). Thus, it was reasoned that some class II–restricted
TCRs, which direct either deletion or CD4 lineage choice
in mice that express CD4, provide a weaker signal in the
absence of CD4, resulting in differentiation to the double-
negative CD4 lineage or the CD8 lineage, respectively.
Many groups have used MHC class II–deficient and
CD4-deficient mice as models to investigate the helper T
cell contribution to the CD8 cytotoxic T cell response to
various forms of antigenic challenge (1, 9–14). In our expe-
rience, the primary response of wild-type and MHC class
II
 
 
 
/
 
 
 
 mice to pathogens such as 
 
Listeria monocytogenes
 
 or
lymphocytic choriomeningitis virus (LCMV) is indistin-
guishable when assayed for numbers of responding CD8 T
cells by tetramer staining or intracellular cytokine staining
(14). This is not the case in CD4
 
 
 
/
 
 
 
 mice (15). We consis-
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tently found that only half or less than the number of effec-
tor CD8 cells specific for MHC class I–restricted peptides
were generated in CD4-deficient animals compared with
wild-type or class II–deficient mice. It did not seem likely
that this reflected a dependency on CD4 T cell help for a
full-blown CD8 response because wild-type levels of effec-
tor CD8 cells were generated in MHC class II knockout
mice that have fewer helper T cells (16, 17). The experi-
ments we present here have led to a different explanation
for the weaker CD8 response to class I–restricted peptides
in CD4
 
 
 
/
 
 
 
 mice. We now suspect that the CD8 T cell
pool in these animals is heavily contaminated with MHC
class II–restricted cells, perhaps 
 
 
 
50%. Together, our stud-
ies have implications for the strength of signal model of lin-
eage commitment and reveal that CD4
 
 
 
/
 
 
 
 mice are a poor
model to study the requirement for T cell help in mount-
ing CD8 T cell responses.
 
Materials and Methods
 
Mice. 
 
Age-matched C57BL/6 (B6), B6.PL-
 
Thy1
 
a
 
/Cy (Thy
1.1
 
 
 
), B6.SJL-
 
Ptprc
 
a
 
Pep3
 
b
 
/BoyJ (Ly5.1
 
 
 
), and CD4
 
 
 
/
 
 
 
 C57BL/6-
CD4
 
tm1Mak
 
 mice were purchased from the Jackson Laboratory.
MHC class II
 
 
 
/
 
 
 
 B6.129-H2-
 
Ab1
 
tm1Glm
 
N12 (ABBN12-M were
backcrossed 12 times to C57BL/6) and 
 
 
 
2
 
-microglobulin 
 
(
 
 
 
2
 
m)
 
 
 
/
 
 
 
B6.129-
 
 
 
2
 
m
 
tm1
 
N12 (B2MN12-M backcrossed 12 times to C57BL/
6) mice were purchased from Taconic. Experiments were initiated
when mice were 6–12 wk of age and were performed according to
Institutional Animal Care and Use Committee guidelines.
 
Bacterial and Viral Infections. 
 
A recombinant 
 
L. monocytogenes
 
strain expressing a secreted form of chicken ovalbumin (rLmOva)
and an erythromycin-resistant marker was provided by H. Shen
(University of Pennsylvania School of Medicine, Philadelphia,
PA) (18). 
 
L. monocytogenes
 
 was grown to stationary phase, ali-
quoted, and frozen at 
 
 
 
80
 
 
 
C. Before infecting mice, bacteria
were thawed, grown to mid-log phase in brain–heart infusion
broth, measured by optical density (A
 
600
 
), and diluted in PBS for
injection. To generate an acute response, mice were infected
with a primary dose equivalent to 2,000 CFU suspended in 200
 
 
 
l PBS by tail vein injection and analyzed 7 d after infection.
Bacteria numbers were accurately confirmed by spreading bacte-
ria samples onto brain–heart infusion plates plus erythromycin.
LCMV (Armstrong strain) stocks were plaque purified on Vero
cells and grown in BHK-21 cells as described previously (19). For
the generation of an acute virus-specific T cell response, mice
were inoculated i.p. with 2 
 
 
 
 10
 
5
 
 PFU of LCMV diluted in 500
 
 
 
l PBS and analyzed 8 d after infection.
 
In Vivo Depletion of CD4 T Cells. 
 
Mice were injected i.p.
with 200 
 
 
 
g of purified anti–mouse CD4 mAb (clone GK1.5) at
days 
 
 
 
3, 
 
 
 
1, and 
 
 
 
3 after infection with rLmOva. Using a non-
competing FITC-conjugated antibody for CD4 (clone RM4.4),
we observed that 
 
 
 
99% of CD4
 
 
 
 T cells were depleted in the
spleen and peripheral blood of mice on the day of infection.
 
Antibodies and Peptides. 
 
The following purified, fluorescently
conjugated antibodies were purchased from BD Biosciences:
anti–IFN-
 
 
 
–FITC (clone XMG1.2), anti–CD4-PerCP (clone
L3T4), and anti–CD8-allophycocyanin (clone 53.6.7). Synthetic
peptides representing the defined rLmOva epitopes (I-A
 
b
 
–
restricted listeriolysin O (LLO)
 
190–201
 
 and H-2K
 
b
 
–restricted
Ova
 
257–264
 
) or LCMV (I-A
 
b
 
–restricted GP
 
61–80
 
 and H-2D
 
b
 
–
restricted GP
 
33–41
 
) were obtained from Invitrogen.
 
Antigen-presenting Cell Cultures. 
 
LPS blasts were generated
from splenocytes cultured in complete RPMI 1640 (supple-
mented with 10% FCS, 2 mM 
 
l
 
-glutamine, 10 mM Hepes, 0.5
 
 
 
M 2-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml
streptomycin) in the presence of 1 
 
 
 
g/ml LPS (Sigma-Aldrich)
for 2 d at 37
 
 
 
C in 7% CO
 
2
 
.
 
Intracellular IFN-
 
 
 
 Staining. 
 
rLmOva- or LCMV-specific
CD8
 
 
 
 T cells were detected by measuring IFN-
 
 
 
 secretion in re-
sponse to immunodominant MHC class I or II peptides using the
Cytofix/Cytoperm Kit Plus (with GolgiPlug; BD Biosciences)
according to manufacturer’s instructions. For T cell stimulation,
3 
 
 
 
 10
 
6
 
 splenocytes were incubated with or without synthetic pep-
tides or 1 
 
 
 
 10
 
6
 
 splenocytes were cocultured with 2 
 
 
 
 10
 
6
 
 LPS
blasts coated with synthetic peptide in a 96-well plate in a volume
of 200 
 
 
 
l. Cells were stimulated with the MHC class I–restricted
peptides (1 
 
 
 
M) Ova
 
257–264
 
 or GP
 
33–41
 
 and the I-A
 
b
 
 MHC class
II–restricted peptides (10 
 
 
 
M) LLO
 
190–201
 
 or GP
 
61–80
 
 for 5 h in
complete RPMI 1640 in the presence of 1 
 
 
 
g/ml of GolgiPlug
(containing brefeldin A; BD Biosciences) at 37
 
 
 
C in 7% CO
 
2
 
.
Cells were washed, stained with anti–CD8-allophycocyanin and
anti-CD4-PerCp, washed, resuspended in permeabilization–fixa-
tion buffer, and stained with anti–IFN-
 
 
 
–FITC for 30 min at
4
 
 
 
C. The cells were washed in PermWash solution, resuspended
in PBS 
 
  
 
1% paraformaldehyde and analyzed on a FACSCali-
bur™ using CELLQuest™ software.
 
Assay for Cell-mediated Cytotoxicity. 
 
Splenocytes from mice
infected with bacteria or virus were assayed ex vivo for their ability
to kill target cells pulsed with MHC class I or class II–restricted
peptides. Splenocytes were seeded in threefold serial dilutions in
triplicate in 96-well round-bottomed plates. LB27.4 target cells ex-
pressing MHC class I and class II were incubated with 
 
51
 
Cr and
synthetic peptides for 1 h at 37
 
 
 
C. Target cells were washed three
times to remove residual peptide and 
 
51
 
Cr and added to effector
cells at 5,000 cells/well. After a 4-h incubation at 37
 
 
 
C, the plates
were centrifuged at 1,500 revolutions/min for 5 min, and cell
supernatants were collected. 100-
 
 
 
l supernatant samples were
counted on an automatic counter (Wizard model 1470; Perkin-
Elmer) to determine the amount of 
 
51
 
Cr release. Spontaneous and
total release were measured by treating the targets cells with 10%
RPMI 1640 or with 2% Triton X-100 detergent, respectively. The
percent specific lysis was calculated as 100 
 
 
 
 (experimental cpm 
 
 
 
spontaneous cpm)/(maximum cpm 
 
 
 
 spontaneous cpm).
 
Adoptive Transfer of Purified CD8
 
 
 
 T Cells. 
 
Lymph nodes
and spleen were removed from naive B6.SJL and CD4
 
 
 
/
 
 
 
 mice.
Single cell suspensions were prepared, and red blood cells were
lysed. The CD8
 
 
 
 T cell subsets were negatively purified by mag-
netic antibody cell sorting (MACS) with a CD8
 
 
 
 
 
 T cell isola-
tion kit following the manufacturer’s instructions (Miltenyi Bio-
tec). The purity of the flow-through fraction was 
 
 
 
85% CD8
 
 
 
.
107 sorted CD8  T cells from CD4-deficient mice (Thy 1.2  and
Ly 5.1 ) and 107 sorted CD8  T cells from B6.SJL (Thy 1.2  and
Ly 5.1 ) were cotransferred into congenic B6.PL (Thy 1.2 
and Ly 5.1 ) host mice via tail vein injection. Mice were infected
24 h later with either rLmOva or LCMV. Intracellular IFN- 
staining was performed 7 and 8 d after infection, respectively.
Results
CD4 /  Mice Generate a Class II–restricted CD8  T Cell
Response after L. monocytogenes Infection.  To investigate
the role of CD4 T cells in protection against an intracellu-
lar bacterium, we analyzed T cell responses to L. monocy-Tyznik et al. 561
togenes in wild-type and CD4 /  mice. Because naturally de-
rived H2b class I–restricted peptides from L. monocytogenes
have not been identified, we took advantage of a recombi-
nant form, rLmOva, that expresses the H-2Kb–restricted
epitope, Ova257–264, as well as the endogenous I-Ab–
restricted CD4 epitope, LLO190–201. Wild-type and CD4 / 
mice were infected with a sublethal dose of rLmOva and T
cell responses were assessed by intracellular IFN-  staining
and 51Cr release assays 7 d after infection. Wild-type mice
responded as expected with strong CD4  T cell responses to
LLO190–201 and strong CD8  T cell responses to Ova257–264
(Fig. 1, A and B). Surprisingly, the CD8  T cell population
in the CD4 /  mice showed good IFN-  responses to
both the class II–restricted LLO190–201 and class I–restricted
Ova257–264 peptides. This pattern of response was also ob-
served in a 4-h 51Cr release assay. In addition to secreting
IFN- , the LLO190–201-specific T cells from both types of
mice were able to kill targets in a short-term assay (Fig. 1
C). Of note was the fact that the magnitude of the CD8 re-
sponse to Ova257–264 in CD4 /  mice was approximately
half of that in wild type (Fig. 1 B). This was a consistent
finding, and a summary of all the comparisons of the CD8
response of wild-type and CD4 /  mice to the Ova257–264
peptide is presented in Fig. 1 D.
CD4 /  Mice Generate a Class II–restricted CD8  T Cell
Response after LCMV Infection.  To address the possibility
that generation of a CD8  cell response to a class II–
restricted peptide could be unique to this L. monocytogenes
peptide, or the consequence of bacterial infection itself, we
immunized wild-type and CD4 /  mice with LCMV. Nat-
urally occurring H-2Db– and I-Ab–restricted antigenic pep-
tides from LCMV infection have been identified, allowing
for the study of both CD4 and CD8 T cell responses. Wild-
type and CD4 /  mice were infected with a sublethal dose
of LCMV Armstrong strain and T cell responses to class
I–restricted GP33–41 and class II–restricted GP61–80 epitopes
Figure 1. Primary response of wild-type and CD4 / 
mice to MHC class I and class II–restricted peptides after
rLmOva infection. 7 d after infection, splenocytes were
stimulated in vitro with LLO190–201, Ova257–264, or no peptide
and stained for levels of intracellular IFN- . (A) Response
of CD4  T cells to peptides. (B) Response of CD8  T
cells to peptides. Numbers indicate the percentage of IFN- –
positive cells in the CD4  or CD8  population. There
were 2.3   106 Ova257–264-specific CD8  T cells in wild-
type spleen and 106 in CD4    spleen. (C) Lysis of 51Cr-
labeled control, Ova257–264, or LLO190–201-coated LB27.4
targets by spleen cells from wild-type (squares) and CD4 / 
mice (diamonds) assayed directly ex vivo. These data are
representative of four independent experiments of two
mice per group. (D) Response of CD8  T cells to Ova257–264
in wild-type and CD4 /  mice. Data represent the average
of eight mice per group.MHC Class II–restricted CD8 T Cells 562
were assessed at day 8 after infection. Similar to the bacterial
infection, viral infection of CD4 /  mice resulted in CD8 
T cells that responded to presentation of the class II–
restricted peptide GP61–80, as determined by IFN-  produc-
tion and cytotoxic killing of peptide-coated target cells (Fig.
2, A and B). Similar to the Ova257–264 response, it was also
consistently observed that the CD8 response to the class
I–restricted GP33–41 peptide was reduced  50% in CD4 / 
mice compared with wild type when expressed as the frac-
tion of total CD8  T cells (Fig. 2 C).
Recognition of LLO190–201 by CD8 T Cells in CD4 / 
Mice Is MHC Class II–restricted. It is possible that the
LLO190–201 peptide binds MHC class I as well as class II. To
investigate whether the CD8  T cell response to this pep-
tide is indeed class II–restricted, synthetic peptides were loaded
onto antigen-presenting cells that express either MHC class
I or class II molecules. LPS blasts were generated from sple-
nocytes isolated from  2m /  and MHC class II /  mice,
pulsed with or without peptides, washed, and incubated
with the indicated effectors. Using LLO190–201-coated LPS
blasts from  2m /  mice, we observed that CD8  T cells
from CD4 /  mice responded as measured by IFN-  pro-
duction, whereas cells from wild-type mice did not (Fig. 3,
left). As expected, there were no observable CD8  cell re-
sponses to LLO190–201-coated LPS blasts from class II / 
mice, indicating that the CD8  population in CD4 / 
mice was responding to the LLO190–201 peptide complexed
with I-Ab (Fig. 3, right).
Class II–restricted CD8  T Cells Are Undetectable in Acutely
CD4-depleted Mice.  We addressed the possibility that class
II–specific CD8  T cells may be present in a normal mouse
but are few or undetectable during acute infections due to
peripheral competition with CD4  T cells specific for the
same epitope. To address this possibility, wild-type mice
were depleted of CD4  cells in vivo using anti-CD4 mAb
just before immunization. As expected, few CD4  cells
were detected in the spleen 7 d after infection with rLmOva
in the CD4-depleted mice (Fig. 4, left). The first difference
observed in these CD4-depleted mice compared with
CD4 /  mice was that the CD8  T cell response to the
H-2Kb–restricted Ova257–264 peptide was similar in both
mice (Fig. 4, right). The second observation was that, un-
Figure 2. Primary response of wild-type and CD4 / 
mice to MHC class I and class II–restricted peptides after
LCMV infection. CD8  T cell responses were measured
8 d after infection by intracellular IFN-  staining and 51Cr
release cytotoxicity assays. (A) Intracellular IFN-  staining
in the CD8  T cell population after in vitro peptide stimu-
lation. Numbers indicate percentage of IFN- –positive
cells in the CD8  population. There were 17.7   106
GP33–41-specific CD8  T cells in wild-type spleen and
6.9   106 in CD4    spleen. (B) 51Cr release assay of con-
trol, GP33–41, or GP61–80 peptide–coated LB27.4 cells by
wild-type (squares) and CD4 /  (diamonds) splenocytes
taken directly ex vivo. These data are representative of
three independent experiments of two mice per group. (C)
Response of CD8  T cells to GP33–41 in wild-type and
CD4 /  mice. Data represent the average of six mice per
group.Tyznik et al. 563
like the CD8 response to LLO190–201 in CD4 /  mice,
CD4-depleted mice did not respond to the class II–restricted
peptide (Fig. 4, right). It is also noteworthy that the hint of a
CD8 response to the class II–restricted peptide observed in
normal B6 mice in Figs. 1–4 is not observed in CD4-
depleted mice. These findings indicate that the mismatch in
coreceptor and MHC recognition is due to abnormal devel-
opment of the T cells in the CD4 /  mice and not due to
peripheral competition for MHC–peptide complexes.
Comparison of Wild Type and Knockout Response in the
Same Environment.  As aforementioned, we observed that
the overall magnitude of the CD8  T cell response to class
I–restricted peptides assessed by intracellular cytokine stain-
ing or cytotoxicity was consistently lower in CD4 /  than
in wild-type mice (Figs. 1 and 2). To determine whether
this was due to helper deficiency in the CD4 /  mice, or is
an intrinsic property of the CD8 population, purified CD8 
T cells from wild-type and CD4 /  mice were mixed in a
1:1 ratio, transferred into adoptive hosts and immunized
with pathogen. After immunization with rLmOva, the IFN- 
response of transferred wild-type CD8  T cells to the Ova
peptide was roughly twofold higher than the response of the
transferred CD4 /  cells in the same infected host (Fig. 5
A). After correcting for the slight skewing of total donor
CD8 T cell numbers after L. monocytogenes infection, there
were 2.5-fold more wild-type than CD4 /  effectors.
There are at least four MHC class I–restricted LCMV
epitopes in C57BL/6 mice that all stimulate significant CD8
responses. The response to LCMV generates a massive, anti-
gen-specific expansion of CD8  T cells (20, 21) and this re-
sulted in a dramatic skewing of wild-type/mutant CD8 T
cell numbers. In adoptive hosts of an equal mixture of wild-
type and mutant CD8  T cells, at 8 d after LCMV infection,
the total number of wild-type cells outnumbers the CD4 / 
numbers by a 3:1 ratio (Fig. 5 B, left). Adoptive hosts that
did not receive LCMV maintained a 1:1 ratio of wild-type
and mutant CD8  T cells (unpublished data). The weaker
response to the single Ova epitope did not result in such a
dramatic shift in the ratio of wild-type to mutant cells after
rLmOva immunization (Fig. 5 A). The IFN-  response to
the H2-Db/GP33–41 epitope is also skewed in favor of the
wild-type CD8  T cells (Fig. 5 B). When one takes into ac-
count the differential expansion of the wild-type and mutant
cells, there are  4.8 times as many GP33–41-specific effectors
of wild-type origin compared with CD4 /  origin. We con-
clude that the environment of the CD4 /  mouse does not ex-
plain their reduced CD8  T cell response to class I–restricted
peptides from L. monocytogenes or LCMV. Rather, some-
thing intrinsic to the CD8 population itself is the cause.
Discussion
We provide evidence for the surprising conclusion that
in CD4 /  mice, the CD8 population contains a large frac-
tion of MHC class II–restricted cells in addition to the con-
ventional class I–restricted cells. In both of the immuniza-
Figure 3. The CD8  response to LLO190–201 in CD4 / 
mice requires peptide presentation on MHC class II
molecules. 7 d after infection with rLmOva, splenocytes
from wild-type or CD4 /  mice were stimulated with
LLO190–201-coated  2m / or MHC class II /  LPS blasts. In-
tracellular IFN-  staining was performed to determine the
percentage of LLO190–201-specific cells in the CD8  T cell
population. These data are representative of three indepen-
dent experiments of two mice per group.
Figure 4. C57BL/6 mice acutely depleted
of CD4  cells do not mount a CD8  T cell
response to MHC class II–restricted pep-
tides. C57BL/6 mice were depleted of
CD4  T cells by three injections of anti-
CD4 mAb and infected with rLmOva.
LLO190–201 and Ova257–264-specific CD4  or
CD8  T cells were quantified by intracellular
IFN-  staining day 7 after infection and after
in vitro stimulation with or without peptide.
Numbers represent the percentage of Ag-
specific cells in the CD4  or CD8  T cell
population. This experiment is representative
of two mice per group from two indepen-
dent experiments.MHC Class II–restricted CD8 T Cells 564
tion systems we studied, these CD8  class II–restricted T
cells were readily apparent. It has also been reported that
the response to murine hepatitis virus in CD4 /  mice
shows a similar, readily detectable CD8 T cell response to
class II–restricted antigen, though in this case the epitopes
were not defined (22). The class II–restricted response of
CD8 lineage cells, which is readily seen in CD4 /  mice, is
not obvious in control animals, where it is difficult to de-
tect any CD8 response to the same MHC class II–restricted
peptides. We have shown that this difficulty in detecting
class II–restricted CD8 cells in a wild-type mouse is not be-
cause conventional CD4 T cells suppress the CD8 response
to the class II/peptide epitopes; even when the CD4 T cell
population is depleted just before immunization, no class
II–restricted CD8 T cell response is revealed (Fig. 4). On
the contrary, we observed that the few events in the IFN- 
staining profiles suggesting that CD8  T cells in normal
mice can respond to class II–restricted peptides were de-
creased in acutely CD4-depleted mice. This suggests that
these events were caused by bystander activation of CD8 
T cells driven by peptide activation of CD4 cells in the cul-
tures. However, we do not rule out the possibility that
there is a very weak response of CD8  T cells to class II–
restricted peptides in normal B6 mice.
Indeed, it is likely that the class II–restricted CD8 T cells
in the CD4 /  animals arise as a result of misdirection dur-
ing positive selection in the thymus (4). We assume that
the cells are selected by recognition of class II in the thy-
mus, where some immature thymocytes express a ran-
domly generated TCR with sufficient affinity for class II
molecules on the thymic cortical epithelial cells that they
can be selected into the CD8 lineage when the CD4 core-
ceptor is absent.
We propose that the main reason why the CD8 response
to class I–restricted peptides in CD4 /  mice appears to be
weaker than the response in control mice is that their TCR
repertoire is heavily contaminated by MHC class II–
restricted cells. It is not explained by the deficiency in T
cell help, as demonstrated best by their weaker response even
when immunized alongside equal numbers of CD8 T cells
from wild-type mice (Fig. 5). It is difficult to estimate pre-
cisely the extent of this contamination. When we compare
the fraction of total CD8 cells making a peptide-specific re-
sponse in intact wild-type or mutant mice, as we did in
Figs. 1 and 2, we find that CD4 /  give roughly half the
wild-type level. However, this does not take into account
the relative starting numbers of CD8 cells or their degree of
expansion after immunization. When equal starting num-
bers of CD8 T cells were mixed and immunized together,
we found that for the Ova257–264 and GP33–41 epitopes, the
wild-type CD8 T cells gave 2.5-fold and 4.8-fold more
progeny than the mutant CD8 T cells, respectively. This
comparison suggests that the CD8 repertoire in CD4 / 
mice may actually contain more class II–restricted receptors
than class I–restricted receptors!
One intriguing question that remains is which immature
thymocytes bearing class II–restricted receptors in CD4 / 
mice are selected into the CD8 lineage, and which ones are
selected into the double-negative CD4 lineage. According
to the strength of signal model for CD4/CD8 lineage
choice, double-positive thymocytes with higher avidity for
the selecting ligand would commit to the CD4 lineage, and
lower avidity cells would preferentially commit to the CD8
lineage (5–8). Although one can readily observe the re-
sponse of the CD8 lineage cells to class II–restricted pep-
tides in CD4 /  mice, a response by the double-negative
CD4 lineage population is not apparent in our studies. One
caveat to this is that we have mainly used IFN-  staining to
detect these cells, and it is possible that the response of
CD4 lineage cells would be detectable using tetramers for
these specificities, or by staining for other cytokines. How-
ever, we have evidence that a similar conclusion is reached
even when intracellular IL-2 staining is used for detection
(unpublished data). In addition, previous work on the re-
sponse of CD4 lineage cells in CD4 /  mice has suggested
that, whereas they can efficiently mount a Th1 response
typified by IFN-  synthesis, they are much less able to
mount a Th2 response (23, 24). Finally, it is clear that the
response of CD4 T cells in wild-type animals is readily de-
tected by intracellular staining for IFN- . Another factor
that may determine our inability to detect the response to
Figure 5. Wild-type CD8  T cells respond better than CD4 /  CD8 
T cells even when immunized in the same host. MACS-sorted CD8 
cells from Ly5.1 B6 and Ly5.2 CD4 /  mice were mixed in a 1:1 ratio
and injected into Thy 1.1 hosts, which were immunized 1 d later with
rLmOva or LCMV. For the analysis, donor T cells were gated as
CD8 Thy1.1  and assessed for CD4 /  (Ly5.1 ) or wild-type (Ly5.1 )
origin. (A) 7 d after rLmOva immunization, the fraction of donor CD8 
T cells making IFN-  in response to Ova peptide was quantitated. Numbers
show the average of five adoptive hosts. (B) 8 d after LCMV immunization,
IFN-  synthesis by donor CD8 cells after in vitro stimulation with H2-Db-
restricted GP33–41 peptide was assessed. Data are representative of two
independent experiments.Tyznik et al. 565
class II–restricted peptides in the double negative CD4 lin-
eage cells in CD4 /  mice is simple numbers. They make
up only 10–20% of the peripheral T cell pool, whereas we
estimate  50% of CD8 lineage cells are class II–restricted.
At present, it is not precisely known what factors deter-
mine the outcome of MHC class II recognition in the thy-
mus of CD4 /  mice, whether it be deletion, selection
into the double-negative “CD4 wannabe” lineage, selec-
tion into the CD8 lineage, or no selection. Similarly, what
controls the response to antigen presented on MHC class II
molecules of peripheral T cells that lack the CD4 corecep-
tor and are either double negative or CD8  is unknown.
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